Engelbrecht-Roberts M, Miles X, Vandevoorde C, de Kock M
Molecules. 2025; 30(5).
PMID: 40076263
PMC: 11902069.
DOI: 10.3390/molecules30051038.
Zeinizade E, Yousefalizideh G, Aminfar P, Horn M, Ding L, Pires L
J Nanobiotechnology. 2025; 23(1):185.
PMID: 40050865
PMC: 11887354.
DOI: 10.1186/s12951-025-03256-7.
Appidi T, China D, Stefan G, Moreau M, Mao S, Velarde E
Mol Cancer. 2025; 24(1):68.
PMID: 40050802
PMC: 11883980.
DOI: 10.1186/s12943-025-02266-1.
Loscertales E, Lopez-Mendez R, Mateo J, Fraile L, Udias J, Espinosa A
Nanoscale Adv. 2025; 7(4):1204-1214.
PMID: 39802332
PMC: 11712209.
DOI: 10.1039/d4na00773e.
cizkova J, Dolezal O, Buchta V, Pospichal J, Blanar V, Sinkorova Z
Front Vet Sci. 2024; 11:1450776.
PMID: 39711799
PMC: 11659289.
DOI: 10.3389/fvets.2024.1450776.
Emerging Fluorescent Nanoparticles for Non-Invasive Bioimaging.
Khalid A, Tomljenovic-Hanic S
Molecules. 2024; 29(23).
PMID: 39683753
PMC: 11643714.
DOI: 10.3390/molecules29235594.
Enhancing targeted doses: Low-energy photon lipiodol-enhanced radiotherapy (LEPERT) for liver cancer patients.
Kawahara D
J Appl Clin Med Phys. 2024; 26(3):e14578.
PMID: 39611766
PMC: 11905249.
DOI: 10.1002/acm2.14578.
Nanomedicine marvels: crafting the future of cancer therapy with innovative statin nano-formulation strategies.
Karimi Jirandehi A, Asgari R, Shahbaz S, Rezaei N
Nanoscale Adv. 2024; .
PMID: 39478996
PMC: 11515941.
DOI: 10.1039/d4na00808a.
Engineering Radiocatalytic Nanoliposomes with Hydrophobic Gold Nanoclusters for Radiotherapy Enhancement.
Carigga Gutierrez N, Clainche T, Bulin A, Leo S, Kadri M, Abdelhamid A
Adv Mater. 2024; 36(50):e2404605.
PMID: 39473330
PMC: 11636064.
DOI: 10.1002/adma.202404605.
Significance of the proton energy loss mechanism to gold nanoparticles in proton therapy: a Geant4 simulation.
Tabbakh F
Sci Rep. 2024; 14(1):24978.
PMID: 39443616
PMC: 11499847.
DOI: 10.1038/s41598-024-76244-w.
Cancer cell membrane-coated siRNA-Decorated Au/MnO nanosensitizers for synergistically enhanced radio-immunotherapy of breast cancer.
Wang D, Lin S, Li T, Yang X, Zhong X, Chen Q
Mater Today Bio. 2024; 29:101275.
PMID: 39403312
PMC: 11471673.
DOI: 10.1016/j.mtbio.2024.101275.
Enhancing radiotherapy for melanoma: the promise of high-Z metal nanoparticles in radiosensitization.
Bemidinezhad A, Radmehr S, Moosaei N, Efati Z, Kesharwani P, Sahebkar A
Nanomedicine (Lond). 2024; 19(28):2391-2411.
PMID: 39382020
PMC: 11492696.
DOI: 10.1080/17435889.2024.2403325.
Microdosimetric Simulation of Gold-Nanoparticle-Enhanced Radiotherapy.
Azarkin M, Kirakosyan M, Ryabov V
Int J Mol Sci. 2024; 25(17).
PMID: 39273472
PMC: 11395083.
DOI: 10.3390/ijms25179525.
Ligand Shell Thickness of PEGylated Gold Nanoparticles Controls Cellular Uptake and Radiation Enhancement.
Lawrence P, Daniels A, Tierney A, Sykes E, Mace C
ACS Omega. 2024; 9(34):36847-36856.
PMID: 39220474
PMC: 11360023.
DOI: 10.1021/acsomega.4c06568.
Breaking the barrier: Nanoparticle-enhanced radiotherapy as the new vanguard in brain tumor treatment.
Liu S, Li M, Liang B, Sun W, Shao Y, Hu X
Front Pharmacol. 2024; 15:1394816.
PMID: 39021831
PMC: 11252536.
DOI: 10.3389/fphar.2024.1394816.
Gold nanoparticle-enhanced radiotherapy: Dependence of the macroscopic dose enhancement on the microscopic localization of the nanoparticles within the tumor vasculature.
Diaz-Galindo C, Garnica-Garza H
PLoS One. 2024; 19(7):e0304670.
PMID: 38968211
PMC: 11226116.
DOI: 10.1371/journal.pone.0304670.
Nanoscale gold nanoparticle (GNP)-laden tumor cell model and its use for estimation of intracellular dose from GNP-induced secondary electrons.
Jayarathna S, Kaphle A, Krishnan S, Cho S
Med Phys. 2024; 51(9):6276-6291.
PMID: 38935922
PMC: 11489034.
DOI: 10.1002/mp.17275.
In Vitro and In Vivo Synergetic Radiotherapy with Gold Nanoparticles and Docetaxel for Pancreatic Cancer.
Alhussan A, Jackson N, Chow N, Gete E, Wretham N, Dos Santos N
Pharmaceutics. 2024; 16(6).
PMID: 38931837
PMC: 11206706.
DOI: 10.3390/pharmaceutics16060713.
Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment.
Jackson N, Cecchi D, Beckham W, Chithrani D
Molecules. 2024; 29(11).
PMID: 38893315
PMC: 11173748.
DOI: 10.3390/molecules29112438.
Innovative therapeutic strategies to overcome radioresistance in breast cancer.
Arnold C, Mangesius J, Portnaia I, Ganswindt U, Wolff H
Front Oncol. 2024; 14:1379986.
PMID: 38873260
PMC: 11169591.
DOI: 10.3389/fonc.2024.1379986.